| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Medicine and The Sam and Rose Stein Institute for Research on Aging, University of California at San Diego, La Jolla, CA 92093
DNA vaccines can stimulate both humoral and cytolytic immune responses. Although bone marrow-derived elements present the expressed Ag, the mechanisms for acquiring immunogenic peptides have yet to be fully elucidated. APCs may become directly transfected by plasmid DNA or process extracellular proteins produced by other transfected cells. Using a transactivating plasmid system and bone marrow chimeras, we show that both mechanisms appear to be involved; however, the bulk of the immune response is dependent on expression of Ag by nonlymphoid tissues and transfer to APCs. These in vivo studies are the first to define the role of transfected nonlymphoid cells in generating Ag for presentation by bone marrow-derived APCs after needle injection with plasmid DNA.
This article has been cited by other articles:
|
|
 |
|
  A. D. Bins, M. C. Wolkers, M. D. van den Boom, J. B. A. G. Haanen, and T. N. M. Schumacher In Vivo Antigen Stability Affects DNA Vaccine Immunogenicity J. Immunol., August 15, 2007; 179(4): 2126 - 2133. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Shirota, L. Petrenko, C. Hong, and D. M. Klinman Potential of Transfected Muscle Cells to Contribute to DNA Vaccine Immunogenicity J. Immunol., July 1, 2007; 179(1): 329 - 336. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Bae, Y.-J. Park, J.-B. Park, Y. S. Choi, M. S. Kim, and J.-I. Sin Therapeutic Synergy of Human Papillomavirus E7 Subunit Vaccines plus Cisplatin in an Animal Tumor Model: Causal Involvement of Increased Sensitivity of Cisplatin-Treated Tumors to CTL-Mediated Killing in Therapeutic Synergy Clin. Cancer Res., January 1, 2007; 13(1): 341 - 349. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. N. Radcliffe, J. S. Roddick, P. S. Friedmann, F. K. Stevenson, and S. M. Thirdborough Prime-Boost with Alternating DNA Vaccines Designed to Engage Different Antigen Presentation Pathways Generates High Frequencies of Peptide-Specific CD8+ T Cells J. Immunol., November 15, 2006; 177(10): 6626 - 6633. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. R. Otten, M. Schaefer, B. Doe, H. Liu, I. Srivastava, J. zur Megede, J. Kazzaz, Y. Lian, M. Singh, M. Ugozzoli, et al. Enhanced Potency of Plasmid DNA Microparticle Human Immunodeficiency Virus Vaccines in Rhesus Macaques by Using a Priming-Boosting Regimen with Recombinant Proteins J. Virol., July 1, 2005; 79(13): 8189 - 8200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Hon, A. Oran, T. Brocker, and J. Jacob B Lymphocytes Participate in Cross-Presentation of Antigen following Gene Gun Vaccination J. Immunol., May 1, 2005; 174(9): 5233 - 5242. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Giri, K. E. Ugen, and D. B. Weiner DNA Vaccines against Human Immunodeficiency Virus Type 1 in the Past Decade Clin. Microbiol. Rev., April 1, 2004; 17(2): 370 - 389. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. P. Nayak, G. Sailaja, and A. M. Jabbar Enhancement of gp120-Specific Immune Responses by Genetic Vaccination with the Human Immunodeficiency Virus Type 1 Envelope Gene Fused to the Gene Coding for Soluble CTLA4 J. Virol., October 15, 2003; 77(20): 10850 - 10861. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Rush, T. Mitchell, and P. Garside Efficient Priming of CD4+ and CD8+ T Cells by DNA Vaccination Depends on Appropriate Targeting of Sufficient Levels of Immunologically Relevant Antigen to Appropriate Processing Pathways J. Immunol., November 1, 2002; 169(9): 4951 - 4960. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. D. de Gruijl, S. A. Luykx-de Bakker, B. W. Tillman, A. J. M. van den Eertwegh, J. Buter, S. M. Lougheed, G. J. van der Bij, A. M. Safer, H. J. Haisma, D. T. Curiel, et al. Prolonged Maturation and Enhanced Transduction of Dendritic Cells Migrated from Human Skin Explants After In Situ Delivery of CD40-Targeted Adenoviral Vectors J. Immunol., November 1, 2002; 169(9): 5322 - 5331. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Rice, S. Buchan, and F. K. Stevenson Critical Components of a DNA Fusion Vaccine Able to Induce Protective Cytotoxic T Cells Against a Single Epitope of a Tumor Antigen J. Immunol., October 1, 2002; 169(7): 3908 - 3913. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Marsac, D. Loirat, C. Petit, O. Schwartz, and M.-L. Michel Enhanced Presentation of Major Histocompatibility Complex Class I-Restricted Human Immunodeficiency Virus Type 1 (HIV-1) Gag-Specific Epitopes after DNA Immunization with Vectors Coding for Vesicular Stomatitis Virus Glycoprotein- Pseudotyped HIV-1 Gag Particles J. Virol., June 27, 2002; 76(15): 7544 - 7553. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Delogu, A. Li, C. Repique, F. Collins, and S. L. Morris DNA Vaccine Combinations Expressing Either Tissue Plasminogen Activator Signal Sequence Fusion Proteins or Ubiquitin-Conjugated Antigens Induce Sustained Protective Immunity in a Mouse Model of Pulmonary Tuberculosis Infect. Immun., January 1, 2002; 70(1): 292 - 302. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Biragyn, M. Surenhu, D. Yang, P. A. Ruffini, B. A. Haines, E. Klyushnenkova, J. J. Oppenheim, and L. W. Kwak Mediators of Innate Immunity That Target Immature, But Not Mature, Dendritic Cells Induce Antitumor Immunity When Genetically Fused with Nonimmunogenic Tumor Antigens J. Immunol., December 1, 2001; 167(11): 6644 - 6653. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Cho, J. W. Youn, and Y. C. Sung Cross-Priming as a Predominant Mechanism for Inducing CD8+ T Cell Responses in Gene Gun DNA Immunization J. Immunol., November 15, 2001; 167(10): 5549 - 5557. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Rice, T. Elliott, S. Buchan, and F. K. Stevenson DNA Fusion Vaccine Designed to Induce Cytotoxic T Cell Responses Against Defined Peptide Motifs: Implications for Cancer Vaccines J. Immunol., August 1, 2001; 167(3): 1558 - 1565. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Vignuzzi, S. Gerbaud, S. van der Werf, and N. Escriou Naked RNA immunization with replicons derived from poliovirus and Semliki Forest virus genomes for the generation of a cytotoxic T cell response against the influenza A virus nucleoprotein J. Gen. Virol., July 1, 2001; 82(7): 1737 - 1747. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-F. Hung, W.-F. Cheng, C.-Y. Chai, K.-F. Hsu, L. He, M. Ling, and T.-C. Wu Improving Vaccine Potency Through Intercellular Spreading and Enhanced MHC Class I Presentation of Antigen J. Immunol., May 1, 2001; 166(9): 5733 - 5740. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Chan, D. J. Lee, A. Schubert, C. M. Tang, B. Crain, S. P. Schoenberger, and M. Corr The Roles of MHC Class II, CD40, and B7 Costimulation in CTL Induction by Plasmid DNA J. Immunol., March 1, 2001; 166(5): 3061 - 3066. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Jilek, C. Barbey, F. Spertini, and B. Corthesy Antigen-Independent Suppression of the Allergic Immune Response to Bee Venom Phospholipase A2 by DNA Vaccination in CBA/J Mice J. Immunol., March 1, 2001; 166(5): 3612 - 3621. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. Maloy, I. Erdmann, V. Basch, S. Sierro, T. A. Kramps, R. M. Zinkernagel, S. Oehen, and T. M. Kündig Intralymphatic immunization enhances DNA vaccination PNAS, February 22, 2001; (2001) 51630798. [Abstract] [Full Text]
|
|
|
|
 |
|
 C.-F. Hung, K.-F. Hsu, W.-F. Cheng, C.-Y. Chai, L. He, M. Ling, and T-C. Wu Enhancement of DNA Vaccine Potency by Linkage of Antigen Gene to a Gene Encoding the Extracellular Domain of Fms-like Tyrosine Kinase 3-Ligand Cancer Res., February 1, 2001; 61(3): 1080 - 1088. [Abstract] [Full Text]
|
|
|
|
|
|
D. Haddad, J. Ramprakash, M. Sedegah, Y. Charoenvit, R. Baumgartner, S. Kumar, S. L. Hoffman, and W. R. Weiss Plasmid Vaccine Expressing Granulocyte-Macrophage Colony-Stimulating Factor Attracts Infiltrates Including Immature Dendritic Cells into Injected Muscles J. Immunol., October 1, 2000; 165(7): 3772 - 3781. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. DONNELLY, M. A. LIU, and J. B. ULMER Antigen Presentation and DNA Vaccines Am. J. Respir. Crit. Care Med., October 1, 2000; 162(4): S190 - 193. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Dupuis, K. Denis-Mize, C. Woo, C. Goldbeck, M. J. Selby, M. Chen, G. R. Otten, J. B. Ulmer, J. J. Donnelly, G. Ott, et al. Distribution of DNA Vaccines Determines Their Immunogenicity After Intramuscular Injection in Mice J. Immunol., September 1, 2000; 165(5): 2850 - 2858. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-T. Qiu, B. Liu, C. Tian, G. N. Pavlakis, and X.-F. Yu Enhancement of Primary and Secondary Cellular Immune Responses against Human Immunodeficiency Virus Type 1 Gag by Using DNA Expression Vectors That Target Gag Antigen to the Secretory Pathway J. Virol., July 1, 2000; 74(13): 5997 - 6005. [Abstract] [Full Text]
|
|
|
|
|
|
G. Delogu, A. Howard, F. M. Collins, and S. L. Morris DNA Vaccination against Tuberculosis: Expression of a Ubiquitin-Conjugated Tuberculosis Protein Enhances Antimycobacterial Immunity Infect. Immun., June 1, 2000; 68(6): 3097 - 3102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Wan, J. Bramson, A. Pilon, Q. Zhu, and J. Gauldie Genetically Modified Dendritic Cells Prime Autoreactive T Cells through a Pathway Independent of CD40L and Interleukin 12: Implications for Cancer Vaccines Cancer Res., June 1, 2000; 60(12): 3247 - 3253. [Abstract] [Full Text]
|
|
|
|
|
|
K. J. Maloy, I. Erdmann, V. Basch, S. Sierro, T. A. Kramps, R. M. Zinkernagel, S. Oehen, and T. M. Kundig Intralymphatic immunization enhances DNA vaccination PNAS, March 13, 2001; 98(6): 3299 - 3303. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
